- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic Factors for Chronic Lymphocytic Leukemia
Authors
Keywords
Chronic lymphocytic leukemia, Treatment, Prognostication
Journal
Current Hematologic Malignancy Reports
Volume 11, Issue 1, Pages 37-42
Publisher
Springer Nature
Online
2016-01-09
DOI
10.1007/s11899-015-0294-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Initial treatment of CLL: integrating biology and functional status
- (2015) N. Jain et al. BLOOD
- The Bruton tyrosine kinase inhibitor ibrutinib with chemoimmunotherapy in patients with chronic lymphocytic leukemia
- (2015) J. R. Brown et al. BLOOD
- Three-year follow-up of treatment-naive and previously treated patients with CLL and SLL receiving single-agent ibrutinib
- (2015) J. C. Byrd et al. BLOOD
- Complex karyotype is a stronger predictor than del(17p) for an inferior outcome in relapsed or refractory chronic lymphocytic leukemia patients treated with ibrutinib-based regimens
- (2015) Philip A. Thompson et al. CANCER
- Integrated CLL Scoring System, a New and Simple Index to Predict Time to Treatment and Overall Survival in Patients With Chronic Lymphocytic Leukemia
- (2015) Andrea Visentin et al. Clinical Lymphoma Myeloma & Leukemia
- Role of microRNA in chronic lymphocytic leukemia onset and progression
- (2015) Veronica Balatti et al. Journal of Hematology & Oncology
- Prognostic signature and clonality pattern of recurrently mutated genes in inactive chronic lymphocytic leukemia
- (2015) A M Hurtado et al. Blood Cancer Journal
- Etiology of Ibrutinib Therapy Discontinuation and Outcomes in Patients With Chronic Lymphocytic Leukemia
- (2015) Kami J. Maddocks et al. JAMA Oncology
- PTK2 expression and immunochemotherapy outcome in chronic lymphocytic leukemia
- (2014) M. Weisser et al. BLOOD
- Validation of ZAP-70 methylation and its relative significance in predicting outcome in chronic lymphocytic leukemia
- (2014) R. Claus et al. BLOOD
- Trisomy 12 chronic lymphocytic leukemia cells exhibit upregulation of integrin signaling that is modulated by NOTCH1 mutations
- (2014) J. C. Riches et al. BLOOD
- Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemia
- (2014) N. Pflug et al. BLOOD
- Minimal residual disease monitoring in chronic lymphocytic leukaemia patients. A comparative analysis of flow cytometry and ASO IgH RQ-PCR
- (2014) Sara Raponi et al. BRITISH JOURNAL OF HAEMATOLOGY
- Italian external and multicentric validation of the MD Anderson Cancer Center nomogram and prognostic index for chronic lymphocytic leukaemia patients: analysis of 1502 cases
- (2014) Massimo Gentile et al. BRITISH JOURNAL OF HAEMATOLOGY
- CD49d Is the Strongest Flow Cytometry–Based Predictor of Overall Survival in Chronic Lymphocytic Leukemia
- (2014) Pietro Bulian et al. JOURNAL OF CLINICAL ONCOLOGY
- Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
- (2014) Richard R. Furman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Microenvironmental Interactions in Chronic Lymphocytic Leukemia: The Master Role of CD49d
- (2014) Michele Dal Bo et al. SEMINARS IN HEMATOLOGY
- The pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemia
- (2013) Gabriele Brachtl et al. ANNALS OF HEMATOLOGY
- Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
- (2013) John C. Byrd et al. NEW ENGLAND JOURNAL OF MEDICINE
- Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia
- (2012) D. Rossi et al. BLOOD
- Bendamustine in Combination With Rituximab for Previously Untreated Patients With Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group
- (2012) Kirsten Fischer et al. JOURNAL OF CLINICAL ONCOLOGY
- Minimal Residual Disease Quantification Is an Independent Predictor of Progression-Free and Overall Survival in Chronic Lymphocytic Leukemia: A Multivariate Analysis From the Randomized GCLLSG CLL8 Trial
- (2012) Sebastian Böttcher et al. JOURNAL OF CLINICAL ONCOLOGY
- Importance of immunoglobulin heavy chain variable region mutational status in del(13q) chronic lymphocytic leukemia
- (2011) Douglas E. Gladstone et al. LEUKEMIA & LYMPHOMA
- High Serum Thymidine Kinase 1 Level Predicts Poorer Survival in Patients With Chronic Lymphocytic Leukemia
- (2010) Sergej N. Konoplev et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- CD49d is an independent prognostic marker that is associated with CXCR4 expression in CLL
- (2010) Aneela Majid et al. LEUKEMIA RESEARCH
- The Prognostic Value of TP53 Mutations in Chronic Lymphocytic Leukemia Is Independent of Del17p13: Implications for Overall Survival and Chemorefractoriness
- (2009) D. Rossi et al. CLINICAL CANCER RESEARCH
- Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia
- (2008) L. Z. Rassenti et al. BLOOD
- Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia
- (2008) C. S. Tam et al. BLOOD
- CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential
- (2008) Tait D. Shanafelt et al. BRITISH JOURNAL OF HAEMATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started